These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21957302)

  • 41. Tissue tropism and target cells of NSs-deleted rift valley fever virus in live immunodeficient mice.
    Gommet C; Billecocq A; Jouvion G; Hasan M; Zaverucha do Valle T; Guillemot L; Blanchet C; van Rooijen N; Montagutelli X; Bouloy M; Panthier JJ
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1421. PubMed ID: 22163058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
    Kainulainen M; Lau S; Samuel CE; Hornung V; Weber F
    J Virol; 2016 Jul; 90(13):6140-7. PubMed ID: 27122577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH.
    Kainulainen M; Habjan M; Hubel P; Busch L; Lau S; Colinge J; Superti-Furga G; Pichlmair A; Weber F
    J Virol; 2014 Mar; 88(6):3464-73. PubMed ID: 24403578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
    Nishiyama S; Lokugamage N; Ikegami T
    J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
    Boshra H; Lorenzo G; Rodriguez F; Brun A
    Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome.
    Benferhat R; Josse T; Albaud B; Gentien D; Mansuroglu Z; Marcato V; Souès S; Le Bonniec B; Bouloy M; Bonnefoy E
    J Virol; 2012 Oct; 86(20):11333-44. PubMed ID: 22896612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge.
    Dodd KA; Bird BH; Metcalfe MG; Nichol ST; Albariño CG
    J Virol; 2012 Apr; 86(8):4204-12. PubMed ID: 22345465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Host Factors for Rift Valley Fever Phlebovirus.
    Balaraman V; Indran SV; Li Y; Meekins DA; Jakkula LUMR; Liu H; Hays MP; Souza-Neto JA; Gaudreault NN; Hardwidge PR; Wilson WC; Weber F; Richt JA
    Viruses; 2023 Nov; 15(11):. PubMed ID: 38005928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
    Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
    Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rift Valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export.
    Copeland AM; Van Deusen NM; Schmaljohn CS
    Virology; 2015 Dec; 486():88-93. PubMed ID: 26410240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Change P82L in the Rift Valley Fever Virus NSs Protein Confers Attenuation in Mice.
    Borrego B; Moreno S; de la Losa N; Weber F; Brun A
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence.
    Terasaki K; Ramirez SI; Makino S
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005047. PubMed ID: 27711108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular biology and genetic diversity of Rift Valley fever virus.
    Ikegami T
    Antiviral Res; 2012 Sep; 95(3):293-310. PubMed ID: 22710362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Making Rift Valley Fever Viral Particles Fluorescent.
    Gu Y; Koch J; Garnier C; Erny A; Lozach PY
    Methods Mol Biol; 2024; 2824():165-188. PubMed ID: 39039413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.
    Bird BH; Albariño CG; Hartman AL; Erickson BR; Ksiazek TG; Nichol ST
    J Virol; 2008 Mar; 82(6):2681-91. PubMed ID: 18199647
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HSP90 is part of a protein complex with the L polymerase of Rift Valley fever phlebovirus and prevents its degradation by the proteasome during the viral genome replication/transcription stage.
    Alem F; Brahms A; Tarasaki K; Omole S; Kehn-Hall K; Schmaljohn CS; Bavari S; Makino S; Hakami RM
    Front Cell Infect Microbiol; 2024; 14():1331755. PubMed ID: 38800833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Culex flavivirus infection in a Culex pipiens mosquito colony and its effects on vector competence for Rift Valley fever phlebovirus.
    Talavera S; Birnberg L; Nuñez AI; Muñoz-Muñoz F; Vázquez A; Busquets N
    Parasit Vectors; 2018 May; 11(1):310. PubMed ID: 29792223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of Rift Valley fever virus N-protein in Nicotiana benthamiana for use as a diagnostic antigen.
    Mbewana S; Meyers AE; Weber B; Mareledwane V; Ferreira ML; Majiwa PAO; Rybicki EP
    BMC Biotechnol; 2018 Dec; 18(1):77. PubMed ID: 30537953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transmission of Rift Valley fever virus from European-breed lambs to Culex pipiens mosquitoes.
    Vloet RPM; Vogels CBF; Koenraadt CJM; Pijlman GP; Eiden M; Gonzales JL; van Keulen LJM; Wichgers Schreur PJ; Kortekaas J
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006145. PubMed ID: 29281642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.